EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MyoRep: A Novel Reporter System to Detect Early Muscle Atrophy In Vitro and In Vivo

Andrea D Re Cecconi, Nicoletta Rizzi, Mara Barone, Federica Palo, Martina Lunardi, Mara Forti, Adriana Maggi, Paolo Ciana, Giulia Terribile, Michela Chiappa, Lorena Zentilin, Rosanna Piccirillo iD

Journal of Cachexia, Sarcopenia and Muscle · 2026-06 · 17 (3)

DOI: 10.1002/jcsm.70296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 12.05.2026. Verfasst von Andrea D Re Cecconi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy. Hauptthemen laut MEDLINE: Muscular Atrophy, Genes, Reporter. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FONDAZIONE CARIPLO-Progetto Giovani Ricercatori, Fondazione AIRC per la Ricerca sul Cancro ETS, Italian Ministry of Health, Ricerca Finalizzata 2021.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Muscle atrophy occurs during physiological (i.e., fasting) and pathological conditions (i.e., cancer) and anticipates death. Since not all patients will undergo muscle wasting, it would be highly useful to identify them soon to intervene early. We aim to generate a reporter system to follow only pathological, but not physiological, muscle wasting through in vivo imaging.

Methods

Comparing the upstream non‐coding regions of a subset of atrophy‐related genes or atrogenes, using the MuRF1 promoter as a backbone, we cloned various promoters upstream of Firefly Luciferase . The best hits selected in vitro were further compared in in vivo imaging if able to sense early atrophy induced by MCG101 sarcoma or sciatic nerve resection through plasmid electroporation or AAV9 injections. The best promoter was used to generate the reporter mouse MyoRep, expressing the cassette in all skeletal and cardiac muscles using the loxP system.

Results

Luciferase assays showed that only the newly generated promoters of MuRF1, one containing glucocorticoid‐responsive elements or GRE (TWIST) ( p ≤ 0.01, 1.7 FC) and a GRE‐less promoter (GREDEL) ( p ≤ 0.0001, 1.6 FC), discriminated the supernatants from cachectic tumoural cells (C26) from non‐cachectic ones (4T1). Comparing both reporters electroporated in leg muscles, we found that GREDEL, but not TWIST, anticipated atrophy by 6 days in MCG101 carriers ( p ≤ 0.05) and by 8 days upon denervation ( p ≤ 0.05), recapitulating MuRF1 inductions. TWIST, but not GREDEL, drove an undesirable bioluminescent signal in vitro to dexamethasone ( p ≤ 0.001, 1.5 FC) and in vivo upon fasting ( p = 0.0553, 3 FC). GREDEL‐carrying AAV9 injected in the legs of Apc Min/+ mice unraveled sex‐different cachexia and anticipated body emaciation by 1 week ( p ≤ 0.001, 3.7 FC). GREDEL was then used to generate the MyoRep mouse. Dorsal view of bioluminescent signal of MCG101‐carrying MyoRep mice increased already 6 days from tumour injection ( p ≤ 0.01, 1.7 FC) when tumour is still unpalpable. Denervated MyoRep mice emitted a signal already 1 day after surgery ( p ≤ 0.05, 1.4 FC), anticipating atrophy. Male Apc Min/+ mice display less musclin in their muscles ( p ≤ 0.05, 0.4 FC) and plasma ( p ≤ 0.01, 0.6 FC). Such mice, when expressing MyoRep in their muscle legs, were given the anti‐catabolic myokine musclin. The emitted signal was decreased by 30% 3 weeks after musclin‐AAV9 administration ( p ≤ 0.05), supporting MyoRep useful to test anti‐atrophic drugs.

Conclusions

Since MyoRep detects only pathological atrophy anticipating wasting, it represents an unprecedented tool to predict it early in diseases with local or systemic atrophy. It could also be useful to identify early biomarkers of atrophy and new drugs at once.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular AtrophyGenes, ReporterAnimalsMicePromoter Regions, GeneticHumansMuscle, SkeletalMaleMuscle Proteins

Stichwörter der Autor:innen

cancer cachexiain vivo imagingmuscle atrophyreporter mouse

Substanzen

Muscle Proteins

Autor:innen und Institutionen

  • Department of Neuroscience, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy.
  • Direzione Servizi per la Ricerca-Settore Animal Care Unit, University of Milan, Milan, Italy.
  • Department of Health Sciences, University of Milan, Milan, Italy.
  • Molecular Medicine, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.

ORCID-Profile: Rosanna Piccirillo

Förderung

  • FONDAZIONE CARIPLO-Progetto Giovani Ricercatori
  • Fondazione AIRC per la Ricerca sul Cancro ETS
  • Italian Ministry of Health, Ricerca Finalizzata 2021

Zitieren

APA

Re Cecconi, A. D., Rizzi, N., Barone, M., Palo, F., Lunardi, M., Forti, M., Maggi, A., Ciana, P., Terribile, G., Chiappa, M., Zentilin, L., & Piccirillo, R. (2026). MyoRep: A Novel Reporter System to Detect Early Muscle Atrophy In Vitro and In Vivo. Journal of Cachexia, Sarcopenia and Muscle, 17(3). https://doi.org/10.1002/jcsm.70296

Vancouver

Re Cecconi AD, Rizzi N, Barone M, Palo F, Lunardi M, Forti M, et al. MyoRep: A Novel Reporter System to Detect Early Muscle Atrophy In Vitro and In Vivo. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(3). doi:10.1002/jcsm.70296

BibTeX
@article{ReCecconi2026,
  author = {Re Cecconi, Andrea D and Rizzi, Nicoletta and Barone, Mara and Palo, Federica and Lunardi, Martina and Forti, Mara and Maggi, Adriana and Ciana, Paolo and Terribile, Giulia and Chiappa, Michela and Zentilin, Lorena and Piccirillo, Rosanna},
  title = {MyoRep: A Novel Reporter System to Detect Early Muscle Atrophy In Vitro and In Vivo},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1002/jcsm.70296}
}
Kostenlos starten →